Chen Kan - Net Worth and Insider Trading
Chen Kan Net Worth
The estimated net worth of Chen Kan is at least $1 Million dollars as of 2025-04-22. Chen Kan is the Core technical personnel of Dizal (Jiangsu) Pharmaceutical Co Ltd and owns about 17,625 shares of Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) stock worth over $1 Million. Details can be seen in Chen Kan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Chen Kan has not made any transactions after 2022-12-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Chen Kan
Chen Kan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Chen Kan owns 1 companies in total, including Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) .
Click here to see the complete history of Chen Kan’s form 4 insider trades.
Insider Ownership Summary of Chen Kan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:688192 | Dizal (Jiangsu) Pharmaceutical Co Ltd | 2022-12-23 | Core technical personnel |
Chen Kan Latest Holdings Summary
Chen Kan currently owns a total of 1 stock. Chen Kan owns 17,625 shares of Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) as of December 23, 2022, with a value of $1 Million.
Latest Holdings of Chen Kan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:688192 | Dizal (Jiangsu) Pharmaceutical Co Ltd | 2022-12-23 | 17,625 | 58.75 | 1,035,469 |
Holding Weightings of Chen Kan
Chen Kan Form 4 Trading Tracker
According to the SEC Form 4 filings, Chen Kan has made a total of 2 transactions in Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Dizal (Jiangsu) Pharmaceutical Co Ltd is the sale of 7,425 shares on December 23, 2022, which brought Chen Kan around $9,356.
Insider Trading History of Chen Kan
- 1
Chen Kan Trading Performance
GuruFocus tracks the stock performance after each of Chen Kan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Chen Kan is 1.86%. GuruFocus also compares Chen Kan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Chen Kan within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Chen Kan's insider trading performs compared to the benchmark.
Performance of Chen Kan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.28 | | | | | |
| Relative Return to S&P 500(%) | 12.86 | | | | | |
Chen Kan Ownership Network
Ownership Network List of Chen Kan
Ownership Network Relation of Chen Kan
Chen Kan Owned Company Details
What does Dizal (Jiangsu) Pharmaceutical Co Ltd do?
Who are the key executives at Dizal (Jiangsu) Pharmaceutical Co Ltd?
Chen Kan is the Core technical personnel of Dizal (Jiangsu) Pharmaceutical Co Ltd. Other key executives at Dizal (Jiangsu) Pharmaceutical Co Ltd include Directors & senior managers & core technical personn , senior management wu qing yi , and senior management lv hong bin .
Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) Insider Trades Summary
Over the past 18 months, Chen Kan made no insider transaction in Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192). Other recent insider transactions involving Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) include a net purchase of 6,914,689 shares made by , a net purchase of 160,972 shares made by , and a net purchase of 26,416 shares made by lv hong bin .
In summary, during the past 3 months, insiders sold 185,311 shares of Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) in total and bought 0 shares, with a net sale of 185,311 shares. During the past 18 months, 185,311 shares of Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) were sold and 7,299,188 shares were bought by its insiders, resulting in a net purchase of 7,113,877 shares.
Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dizal (Jiangsu) Pharmaceutical Co Ltd Insider Transactions
Chen Kan Mailing Address
Above is the net worth, insider trading, and ownership report for Chen Kan. Currently GuruFocus does not have mailing address information for Chen Kan.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
